Evidence-Based Medicine Guidelines
Antithrombotic therapy for women considered at risk of placental dysfunction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antithrombotic Therapy for Women Considered at Risk of Placental Dysfunction." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457257/all/Antithrombotic_therapy_for_women_considered_at_risk_of_placental_dysfunction.
Antithrombotic therapy for women considered at risk of placental dysfunction. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457257/all/Antithrombotic_therapy_for_women_considered_at_risk_of_placental_dysfunction. Accessed October 11, 2024.
Antithrombotic therapy for women considered at risk of placental dysfunction. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457257/all/Antithrombotic_therapy_for_women_considered_at_risk_of_placental_dysfunction
Antithrombotic Therapy for Women Considered at Risk of Placental Dysfunction [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457257/all/Antithrombotic_therapy_for_women_considered_at_risk_of_placental_dysfunction.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antithrombotic therapy for women considered at risk of placental dysfunction
ID - 457257
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457257/all/Antithrombotic_therapy_for_women_considered_at_risk_of_placental_dysfunction
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
